WFRF:(Lindbäck Stefan)
Search: WFRF:(Lindbäck Stefan) > Medical Resource Ut...
- 2 of 29
- Previous record
- Next record
- To hitlist
- Ghatnekar, Ola (author)
Medical Resource Utilization and Cost of HIV-Related Care in the Highly Active Antiretroviral Therapy Era at a University Clinic in Sweden.
- Article/chapterEnglish2010
Publisher, publication year, extent ...
- 2012-10-14
- Springer Science and Business Media LLC,2010
Numbers
- LIBRIS-ID:oai:gup.ub.gu.se/132355
- https://gup.ub.gu.se/publication/132355URI
- https://doi.org/10.2165/11587440-000000000-00000DOI
Supplementary language notes
- Language:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- Introduction: Little is known regarding healthcare costs for HIV/AIDS patients in the era of highly active antiretroviral therapy (HAART) and subgroups of patients according to the severity and progression of HIV infection in Sweden. The objective of this study is therefore to describe the direct medical resource use and cost of healthcare for HIV patients at a university clinic in Sweden. Methods: A patient registry database for HIV treatment at the Department of Infectious Diseases, Sahlgrenska University Hospital, between 2000 and 2005 provided information on patient characteristics, antiretroviral drugs and dosages, tests and diagnostic procedures, outpatient visits and inpatient stays. The review used publicly available unit costs with a county council perspective, expressed in 2006 Euros. Results: Two hundred and eighty-five patients with a mean age of 38 years in 2000 (64% men) were followed for 1368 patient-years. They had a mean (median) of 6.3 (0) inpatient days, 4.1 (3.7) physician visits, 4.2 (3.8) nurse visits, 2.6 (0.7) counsellor visits and 11.5 (7.7) tests and diagnostic procedures per patient-year. Only 12 deaths were recorded during the study period, and the proportion of treated patients with successful treatment (HIV-RNA <50copies/mL) increased from 74% to 92% during the period. The mean cost per patient-month amounted to &U20AC;1069. The main cost driver was HIV drugs (51%), followed by inpatient stays (including hospitalizations for opportunistic infections; 22%), outpatient physician, nurse or therapist visits (19%) and diagnostics and tests (7%). All non-drug costs increased with a decreasing CD4 cell count. Conclusions: Overall, approximately half of the direct costs of HIV treatment were not related to antiretroviral treatment. The non-antiretroviral costs were inversely correlated with HIV-induced immune deficiency.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
- Hjortsberg, Catharina (author)
- Gisslén, Magnus,1962Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine(Swepub:gu)xgissm (author)
- Lindbäck, Stefan (author)
- Löthgren, Mickael (author)
- Göteborgs universitetInstitutionen för biomedicin, avdelningen för infektionssjukdomar (creator_code:org_t)
Related titles
- In:PharmacoEconomics: Springer Science and Business Media LLC28:S1, s. 49-571179-20271170-7690
Internet link
Find in a library
- PharmacoEconomics (Search for host publication in LIBRIS)
To the university's database
- 2 of 29
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Ghatnekar, Ola
- Hjortsberg, Cath ...
- Gisslén, Magnus, ...
- Lindbäck, Stefan
- Löthgren, Mickae ...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Basic Medicine
- and Microbiology in ...
- Articles in the publication
- PharmacoEconomic ...
- By the university
- University of Gothenburg
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
